Tengion (TNGNQ) Short Interest Ratio & Short Volume

Short interest is the volume of Tengion shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 100 shares of TNGNQ short. Learn More on Tengion's current short interest.

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Tengion: Alvotech (0.11%), Gene Biotherapeutics, Inc. (0.00%), Amgen Inc. (1.79%), Gilead Sciences, Inc. (1.71%), Moderna, Inc. (6.75%), Biogen Inc. (2.51%), Novozymes A/S (0.00%), argenx SE (2.98%), BioNTech SE (1.42%), Neurocrine Biosciences, Inc. (2.61%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks.

Short selling TNGNQ is an investing strategy that aims to generate trading profit from Tengion as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tengion occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TNGNQ, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNGNQ, twice per month. The most recent reporting period available is January, 15 2024.